GEERA DESAI: Open Payments
NPI 1184684961 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 49 payments from 11 companies in 2025. Trend: 2023 $1,579 · 2024 $1,030 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $201 |
| Alkermes, Inc. | 4 | $189 |
| Janssen Pharmaceuticals, Inc | 6 | $177 |
| Otsuka America Pharmaceutical, Inc. | 13 | $175 |
| ABBVIE INC. | 8 | $161 |
| Novo Nordisk Inc | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 4 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $23 |
Products named: COBENFY, INVEGA SUSTENNA, VRAYLAR, ARISTADA, Wegovy, REXULTI, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across SC — which companies pay providers there.
